Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced that its management will present and host 1x1 meetings at the 43rd Annual J.P. Morgan Healthcare Conference being held on January 13-16, 2025 in San Francisco, CA.
Jonathan Dickinson, Chief Executive Officer of Innate Pharma, will represent the Company in a session scheduled Tuesday, January 14, 2025 from 11:15 - 11:55 am PST.
Other Executive Board members participating in the event will be:
- Dr Sonia Quaratino, EVP, Chief Medical Officer
- Yannis Morel, EVP, Chief Operating Officer
- Arvind Sood, EVP, President of US Operations
A live video webcast of the presentation will be accessible under the “Events” tab on the Investors section of the Company’s website at www.innate-pharma.com and will be available for replay following the event.
| Press Release in English | 126.99 KB |
| Communiqué de presse en français | 112.61 KB |